USP <659>: What Pharmaceutical Storage Compliance Really Means

Every product with a temperature label claim carries an implicit promise: that the conditions on the label are the conditions the product actually experienced. USP <659>, the general chapter of the United States Pharmacopeia (USP) that addresses packaging and storage requirements, provides the standardized conditions and terminology relevant to the storage and distribution of pharmaceutical products.

According to Stephanie Punter, ELPRO’s Team Lead GxP & Projects, Deputy Quality for the Americas, the chapter itself is straightforward. Where companies can fall short is demonstrating that the required conditions are actually being maintained.

“USP <659> basically defines the storage conditions we use within the pharmaceutical and life sciences industries: things like controlled room temperature, controlled cold temperature, refrigerator and freezer,” Punter explained.

“It matters because if you’re storing a product that has a defined temperature requirement, you need to be able to show that you’re maintaining it. It’s not enough to say, ‘Our warehouse is temperature controlled.’ How do you know? What evidence do you have to support that?"

Stephanie Punter, Team Lead GxP & Projects, Deputy Quality for the Americas, ELPRO

This is where qualification, mapping and ongoing monitoring come in, topics addressed in greater detail across the broader USP <1079> series. For example, USP <1079.4> specifically addresses temperature mapping for the qualification of storage areas, while <1079.3> focuses on temperature and humidity monitoring devices.

USP <1079> and <659>: What Changed and What It Means for Pharmaceutical Storage

The storage condition definitions companies rely on today were previously addressed across different areas of USP guidance. Understanding why they were brought into <659> helps explain why <659> carries the weight it does.

"The main difference is that <1079> provides guidance on good storage and distribution practices, whereas <659> contains the USP definitions and requirements associated with packaging and storage conditions,” said Punter. “Bringing the storage-condition definitions into <659> therefore gave them a clearer compendial home. Terms such as controlled room temperature and controlled cold temperature are not simply recommendations for how a company might manage storage; they are defined USP storage conditions that provide the framework for interpreting and demonstrating compliance with applicable storage requirements."

In effect, the restructuring created a clearer distinction between the USP chapter that defines packaging and storage requirements and the guidance focused on managing the risks associated with storage and distribution.

Controlled Cold Temperature and MKT: Where Companies Struggle

Controlled cold conditions and the evaluation of temperature excursions are areas where the distinction between maintaining a required storage condition and assessing an excursion becomes particularly important.

USP <1079.2> provides specific guidance on the use of mean kinetic temperature (MKT) in evaluating temperature excursions during storage and transportation. Importantly, USP makes clear that MKT can be a valuable tool for evaluating an excursion but should not be used to normalize storage conditions that are out of control.

"Collecting the data is usually the easy part. Knowing what to do with it is where companies can struggle,” Punter said. “You can have a monitoring system collecting temperatures every few minutes, but then you have an excursion and the question becomes, now what? How high or low did the temperature go? How long was it there? What product was affected? What does the stability data say? What is the potential impact?"

"MKT can help with that assessment, but it shouldn’t just be used to make an excursion disappear because the overall MKT still looks acceptable. You still need to understand what actually happened and whether the product could have been affected."

Stephanie Punter, Team Lead GxP & Projects, Deputy Quality for the Americas, ELPRO

MKT can help quantify the effect of temperature exposure, but it does not simply negate an excursion. USP describes MKT as an excursion-evaluation tool rather than a mechanism for normalizing uncontrolled storage conditions.

The Most Common Misunderstanding: Monitoring Isn’t the Same as Control

When asked what companies commonly get wrong when managing pharmaceutical storage conditions, Stephanie points to a specific assumption.

"One of the biggest things I see is companies thinking that because they have temperature monitoring, they are covered. A sensor tells you what’s happening where that sensor is. It doesn’t tell you what’s happening 50 feet away, at the top of the racking, beside a loading door or underneath an HVAC supply."

Stephanie Punter, Team Lead GxP & Projects, Deputy Quality for the Americas, ELPRO

"That’s why temperature mapping is critical," she explained. "You need to understand how the area behaves, where your hot and cold spots are and what happens during normal operation. Then you can use that information to decide where your permanent monitoring sensors need to be. So, qualification and monitoring really go hand in hand. One doesn’t replace the other."

USP <1079.4> recognizes that numerous factors can affect the ability of a storage area to maintain acceptable temperature ranges, including airflow, heating and air conditioning, insulation, doors, traffic, geography and the orientation of the physical structure.

A monitoring program that is not supported by an adequate understanding of how the storage environment performs may therefore rely on assumptions rather than demonstrated risk.

Where to Start: Assessing the Gaps

For companies unsure whether their current practices appropriately support their storage requirements, Stephanie recommends starting with the basics rather than assuming a problem, or assuming everything is fine.

"A gap assessment is a really good place to start," she said. "You may find that you’re already doing a lot of the right things and just need to strengthen the documentation or justification around them."

A structured gap assessment can help identify both strengths and areas that may require additional justification, documentation, or improvement.

Consider working through the following questions:

What are you storing, and what conditions are required?

Before assessing the controls in place, clearly define:

• The products being stored

• Their labeled storage requirements

• Any temperature, humidity, light, or other environmental controls that must be maintained

Understanding the required storage conditions establishes the baseline against which the storage environment and monitoring program should be evaluated.

How are you demonstrating that those conditions are maintained?

Having a storage requirement is only part of the equation. The next step is determining how you can objectively demonstrate that the required conditions are consistently maintained. This includes reviewing both the monitoring technology in place and the qualification data supporting how the storage environment behaves.

Has the storage area been qualified and mapped?

Temperature mapping provides an important foundation for understanding a storage environment. USP <1079.4> specifically addresses temperature mapping for the qualification of storage areas and recognizes the multiple environmental and operational factors that can affect a space’s ability to maintain labeled temperature ranges. Qualification and mapping studies can help identify temperature variations and areas of potential risk within the space.

Without this data, it can be difficult to demonstrate that environmental conditions are adequately understood and controlled.

Are monitoring locations based on mapping results?

Monitoring points should be selected using an understanding of how the storage environment performs, rather than convenience or assumption. The goal is to position sensors where they are most likely to detect early and meaningful environmental changes that could pose a risk to product quality. Mapping provides evidence that can support and justify those decisions.

Are your sensors calibrated?

Even the best-designed monitoring program depends on reliable measurement devices. Review calibration records to ensure sensors are calibrated at appropriate intervals, remain within acceptable tolerances, and are suitable for their intended use. USP <1079.3> specifically addresses monitoring devices used for time, temperature and humidity and includes recommendations for qualifying their performance.

Are your alarm limits appropriate?

Alarm thresholds should consider both product requirements and the storage conditions being maintained. Limits that are unnecessarily narrow may generate excessive alarms and investigations, while limits that are too broad may fail to provide sufficient warning of a developing environmental problem. The important question is whether the selected limits can be scientifically and operationally justified.

What happens when an alarm or excursion occurs?

Perhaps the most important question is what happens after a temperature alarm or excursion is detected.

Organizations should have:

• Defined response procedures

• Clear responsibilities for investigation

• Processes for impact assessment

• Documentation requirements

• Corrective and preventive action processes

An alarm is only valuable if there is an effective process for evaluating and responding to it.

Designing a Monitoring Program That Holds Up

A monitoring program designed to support applicable pharmaceutical storage requirements needs to be built on evidence, not convenience.

"It all comes back to the temperature mapping data," said Punter. "Don’t just put a sensor somewhere because there’s a convenient outlet or it’s easy to get to. You should be able to explain why it’s there. Your mapping gives you a picture of how the space behaves and helps identify the areas you need to pay attention to. You can then use that information to establish your permanent monitoring locations."

"After that, you need the basics in place: calibrated sensors, sensible alert and alarm limits, defined responsibilities and a process for dealing with excursions," Punter continued. "And somebody needs to review the data."

That last point is important. Collecting data is only part of the equation. Someone must routinely review the information, assess trends, and respond when abnormal conditions emerge. Without that oversight, organizations may generate vast amounts of data without gaining meaningful insight into the state of their storage environment.

What Non-Compliance Means: Company, Customer, Patient

The consequences of being unable to demonstrate that required storage conditions were maintained can extend well beyond an audit finding, though Stephanie is careful to distinguish between a gap in evidence and a confirmed product problem.

"It doesn’t automatically mean you have bad product, but you do have a question that needs to be answered. If you can’t demonstrate that the required storage conditions were maintained, you need to understand what happened and whether the product could have been affected."

Stephanie Punter, Team Lead GxP & Projects, Deputy Quality for the Americas, ELPRO

"That could mean an investigation, reviewing stability data, putting product on hold or, depending on the outcome, potentially losing product," Punter explained. "For the company, that’s time, money and disruption. For the customer, it can mean delays and supply issues."

That’s the throughline in all of this: a mapping study, a calibration record, an MKT calculation. Each is a small piece of evidence that, together, helps a company maintain confidence in a product throughout storage and distribution. Ultimately, that evidence isn’t just about being ready for an audit. It’s about supporting product quality and helping ensure patients receive products that have been stored and handled as intended.

Where the Focus Is Heading

Asked what companies should be watching going forward, Stephanie points to a growing emphasis on understanding and demonstrating control, rather than simply collecting data.

"I think we’re seeing less of a 'put some loggers in there and call it good' mentality and much more focus on understanding the actual risk. For me, the biggest takeaway for companies should be that having data isn’t the same as having control."

Stephanie Punter, Team Lead GxP & Projects, Deputy Quality for the Americas, ELPRO

That shift reflects the risk-based approach found throughout current USP storage and transportation guidance. Rather than simply collecting temperature data, organizations are increasingly expected to understand what that data says about the performance of their storage environment and how it relates to product quality.

Questions that once may have received little scrutiny are increasingly important when demonstrating control. Why was a particular monitoring location selected? What did the mapping study reveal about the storage area? How does the environment respond to routine operations such as door openings, changes in inventory levels, or variations in room utilization? And when an excursion occurs, is there a defined process for assessing impact and taking appropriate action?

The broader USP <1079> series reinforces this approach, with specific guidance addressing areas including mean kinetic temperature and excursion evaluation in <1079.2>, monitoring devices in <1079.3>, and temperature mapping for the qualification of storage areas in <1079.4>.

Together, these concepts encourage organizations to move beyond basic data collection and toward a deeper understanding of how their storage environments perform under real-world conditions.